Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
17.55
+0.17 (0.98%)
Nov 22, 2024, 4:00 PM EST - Market closed
Pacira BioSciences Market Cap
Pacira BioSciences has a market cap or net worth of $810.34 million as of November 22, 2024. Its market cap has decreased by -43.23% in one year.
Market Cap
810.34M
Enterprise Value
1.00B
1-Year Change
-43.23%
Ranking
Category
Stock Price
$17.55
Market Cap Chart
Since February 3, 2011, Pacira BioSciences's market cap has increased from $121.00M to $810.34M, an increase of 569.70%. That is a compound annual growth rate of 14.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 772.50M | -50.70% |
| Dec 29, 2023 | 1.57B | -11.56% |
| Dec 30, 2022 | 1.77B | -33.90% |
| Dec 31, 2021 | 2.68B | 3.10% |
| Dec 31, 2020 | 2.60B | 37.52% |
| Dec 31, 2019 | 1.89B | 6.88% |
| Dec 31, 2018 | 1.77B | -4.50% |
| Dec 29, 2017 | 1.85B | 53.30% |
| Dec 30, 2016 | 1.21B | -57.20% |
| Dec 31, 2015 | 2.82B | -11.70% |
| Dec 31, 2014 | 3.20B | 65.79% |
| Dec 31, 2013 | 1.93B | 239.05% |
| Dec 31, 2012 | 568.70M | 281.68% |
| Dec 30, 2011 | 149.00M | 23.14% |
| Feb 3, 2011 | 121.00M | - |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 812.11M |
| Capricor Therapeutics | 808.91M |
| Castle Biosciences | 808.85M |
| Embecta | 807.83M |
| AbCellera Biologics | 803.40M |
| Avid Bioservices | 783.46M |
| Kura Oncology | 782.30M |
| Pliant Therapeutics | 781.97M |